Free Trial

Kyle Bauser Analyst Performance

Managing Director, Senior Research Analyst at Roth Mkm

Kyle Bauser is a stock analyst at Roth Mkm focused in the medical sector, covering 21 publicly traded companies. Over the past year, Kyle Bauser has issued 27 stock ratings, including strong buy, buy, and hold recommendations. While full access to Kyle Bauser's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Bauser's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
52 Last 6 Years
Buy Recommendations
94.12% 48 Buy Ratings
Companies Covered
21 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy5.9%3 ratings
Buy88.2%45 ratings
Hold5.9%3 ratings
Sell0.0%0 ratings

Out of 51 total stock ratings issued by Kyle Bauser at Roth Mkm, the majority (88.2%) have been Buy recommendations, followed by 5.9% Strong Buy and 5.9% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
71.4% of companies on NASDAQ
15 companies
NYSE
14.3% of companies on NYSE
3 companies
NYSEAMERICAN
9.5% of companies on NYSEAMERICAN
2 companies
OTCMKTS
4.8% of companies on OTCMKTS
1 company

Kyle Bauser, an analyst at Roth Mkm, currently covers 21 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
19 companies
90.5%
Industrials
1 company
4.8%
Manufacturing
1 company
4.8%

Kyle Bauser of Roth Mkm specializes in stock coverage within the Medical sector, with additional focus on Industrials and Manufacturing companies.

Coverage Industries

IndustryPercentage
MED PRODUCTS
6 companies
28.6%
MED INSTRUMENTS
5 companies
23.8%
SURGICAL & MEDICAL INSTRUMENTS
2 companies
9.5%
MED - BIOMED/GENE
2 companies
9.5%
MED - DRUGS
2 companies
9.5%
ELECTROMEDICAL EQUIPMENT
1 company
4.8%
CONTNRS - PPR/PLS
1 company
4.8%
INDUSTRIAL MEASUREMENT INSTRUMENTS & RELATED PRODUCTS
1 company
4.8%
MEDICAL INFO SYS
1 company
4.8%

About Kyle Bauser

Kyle Bauser, Ph.D. is a Managing Director, Senior Research Analyst at ROTH covering the medical technology sector. He began his career in medtech equity research over 12 years ago at Piper Sandler. He later worked in marketing and corporate development at Vascular Solutions before returning to research at Dougherty & Co where he became Managing Director and Co-Head of Equities. His research primarily focuses on smid cap, underfollowed companies with novel technologies. Kyle studied Mathematical Economics and Pre-Med at Colorado College as an undergraduate and earned a Ph.D. in Economics at the City University of New York Graduate Center.
Follow on LinkedIn

Kyle Bauser's Ratings History at Roth Mkm

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
3/30/2026Reiterated Rating$17.23$47.00Buy
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2/26/2026Reiterated Rating$109.09$117.00Buy
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
2/24/2026Reiterated Rating$8.51$15.00Buy
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2/18/2026Boost Price Target$28.05$32.00Neutral
Electromed, Inc. stock logo
ELMD
Electromed
2/11/2026Reiterated Rating$28.06$38.00Buy
iRadimed Corporation stock logo
IRMD
iRadimed
2/10/2026Reiterated Rating$104.85$120.00Buy
Apyx Medical Corporation stock logo
APYX
Apyx Medical
12/15/2025Initiated Coverage$3.79$6.00Buy
Apyx Medical Corporation stock logo
APYX
Apyx Medical
12/15/2025Upgrade$3.72Strong-Buy
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
12/3/2025Initiated Coverage$2.21$5.50Buy
Electromed, Inc. stock logo
ELMD
Electromed
11/13/2025Reiterated Rating$26.00$36.00Buy
Stereotaxis Inc. stock logo
STXS
Stereotaxis
11/12/2025Reiterated Rating$2.39$4.00Buy
Stereotaxis Inc. stock logo
STXS
Stereotaxis
11/5/2025Reiterated Rating$2.80$4.00Buy
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
11/5/2025Reiterated Rating$86.90$108.00Buy
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
11/4/2025Reiterated Rating$9.46$14.00Buy
iRadimed Corporation stock logo
IRMD
iRadimed
10/31/2025Set Price Target$76.42$90.00
iRadimed Corporation stock logo
IRMD
iRadimed
10/31/2025Reiterated Rating$76.81Buy
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
10/7/2025Set Price Target$40.82$53.00Buy
Electromed, Inc. stock logo
ELMD
Electromed
8/27/2025Boost Price Target$24.45$35.00Buy
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
8/22/2025Boost Price Target$44.23$55.00Buy
Varex Imaging stock logo
VREX
Varex Imaging
8/8/2025Reiterated Rating$7.81$16.00Buy
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
8/5/2025Reiterated Rating$11.99$13.00Neutral
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
7/29/2025Initiated Coverage$35.75$49.00Buy
Electromed, Inc. stock logo
ELMD
Electromed
7/22/2025Initiated Coverage$18.13$29.00Buy
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
7/22/2025Initiated Coverage$5.51$12.00Buy
Electromed, Inc. stock logo
ELMD
Electromed
7/21/2025Upgrade$18.69Strong-Buy
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
7/21/2025Upgrade$5.75Strong-Buy
Bio-Techne Corp stock logo
TECH
Bio-Techne
7/9/2025Initiated Coverage$52.68$65.00Buy
Electromed, Inc. stock logo
ELMD
Electromed
2/20/2025Initiated Coverage$29.36$38.00Buy
Varex Imaging stock logo
VREX
Varex Imaging
2/7/2025Reiterated Rating$12.06$22.00Buy